Accreditation Information

Nurse Practitioners and Nurses: This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hour, including up to 0.25 pharmacology hours. Credit can be applied toward the nursing continuing education requirements of most professional organizations and State Boards of Nursing.

Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ARHP designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Others: A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 Credit™.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This program is made possible through educational grants from Actavis, Bayer HealthCare Pharmaceuticals, and Merck and Co.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Amna Dermish, MD (presenter) is a Merck Nexplanon trainer and an Actavis Liletta trainer. Carole Chrvala, PhD (medical writer) has nothing to disclose. Diane Shannon, MD (medical writer) has nothing to disclose. Rana Suliman, MPH (ARHP program manager) has nothing to disclose.